Ken, Sincere question. Who sponsored the study?
Post# of 145712
![](/assets/46931549/no_avatar_available_thumb.jpg)
Sincere question. Who sponsored the study? Not Merck. I’m sure. I think MD Anderson in Houston. I thought it was a little more of a University setting instead of a BP setting.
Anyhoo. The combo data with a PD-1 inhibitor/blocker, such as Keytruda should yield positive results. Im just not convinced it means Merck has any interest in buying us for an amazing price. I hope I’m wrong.
One thing a set of solid data with LL being combined with a PD-1 Inhibitor/blocker should result in is simple. That the PD-1 blocked is no longer necessary.
GLTA
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)